Ativo Capital Management’s Merck MRK Stock Holding History

Ativo Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20,123	Closed	-$1.08M	–	240
2017 Q4	$1.08M	Sell	20,123 -1,551	-7%	-$86K	0.29%	166
2017 Q3	$1.32M	Sell	21,674 -3	-0%	-$182	0.36%	106
2017 Q2	$1.33M	Sell	21,677 -3,667	-14%	-$223K	0.36%	107
2017 Q1	$1.54M	Sell	25,344 -2,114	-8%	-$128K	0.38%	85
2016 Q4	$1.54M	Buy	+27,458	New	+$1.61M	0.36%	88

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ativo Capital Management's MRK Position: Q1 2018 in Review

Ativo Capital Management sold out of Merck (MRK) in Q1 2018, closing a stake of 20,123 shares — an estimated $1.08M sold.

Ativo Capital Management first reported a position in MRK in Q4 2016 and held it in 5 quarters. The position peaked at $1.54M in Q4 2016. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

Ativo Capital Management reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
Ativo Capital Management sold 20,123 Merck shares in Q1 2018, an estimated $1.08M.
Ativo Capital Management first reported a position in Merck in Q4 2016 and held it in 5 quarters.
Ativo Capital Management's Merck position peaked at $1.54M in Q4 2016.
1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Ativo Capital Management's 13F filing for Q1 2018, filed 15 May 2018.